BR112014031143B8 - Método para quantificar células imunes em tecidos tumorais e suas aplicações - Google Patents
Método para quantificar células imunes em tecidos tumorais e suas aplicaçõesInfo
- Publication number
- BR112014031143B8 BR112014031143B8 BR112014031143A BR112014031143A BR112014031143B8 BR 112014031143 B8 BR112014031143 B8 BR 112014031143B8 BR 112014031143 A BR112014031143 A BR 112014031143A BR 112014031143 A BR112014031143 A BR 112014031143A BR 112014031143 B8 BR112014031143 B8 BR 112014031143B8
- Authority
- BR
- Brazil
- Prior art keywords
- immune cells
- tumor
- tumor tissues
- applications
- analyzed
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2012001446 | 2012-06-14 | ||
IBPCT/IB2012/001446 | 2012-06-14 | ||
PCT/EP2013/062405 WO2013186374A1 (en) | 2012-06-14 | 2013-06-14 | Method for quantifying immune cells in tumoral tissues and its applications |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014031143A2 BR112014031143A2 (pt) | 2017-08-08 |
BR112014031143B1 BR112014031143B1 (pt) | 2022-03-03 |
BR112014031143B8 true BR112014031143B8 (pt) | 2022-11-22 |
Family
ID=46881097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014031143A BR112014031143B8 (pt) | 2012-06-14 | 2013-06-14 | Método para quantificar células imunes em tecidos tumorais e suas aplicações |
Country Status (13)
Country | Link |
---|---|
US (1) | US10317408B2 (pt) |
EP (1) | EP2861986B1 (pt) |
JP (1) | JP6449765B2 (pt) |
KR (1) | KR102179848B1 (pt) |
CN (1) | CN104541167B (pt) |
AU (1) | AU2013276470B2 (pt) |
BR (1) | BR112014031143B8 (pt) |
CA (1) | CA2873278C (pt) |
DE (1) | DE13731071T1 (pt) |
ES (1) | ES2902879T3 (pt) |
IL (1) | IL235738B (pt) |
SG (1) | SG11201408107RA (pt) |
WO (1) | WO2013186374A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3111221B2 (en) | 2014-02-24 | 2022-01-19 | Ventana Medical Systems, Inc. | Methods, kits, and systems for scoring the immune response to cancer by simultaneous detection of cd3, cd8, cd20 and foxp3. |
WO2016034655A2 (en) * | 2014-09-03 | 2016-03-10 | Ventana Medical Systems, Inc. | Systems and methods for generating fields of view |
US11275080B2 (en) | 2014-11-05 | 2022-03-15 | The Regents Of The University Of California | Methods for stratifying non-responders to therapies that block PD1/PDL1 axis |
WO2016118832A1 (en) | 2015-01-22 | 2016-07-28 | University Of Massachusetts | Cancer immunotherapy |
US10705088B2 (en) * | 2015-10-23 | 2020-07-07 | Novartis Ag | Method of scoring a sample comprising tumor tissue |
PL3455631T3 (pl) * | 2016-05-09 | 2021-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Sposoby klasyfikowania pacjentów z nowotworem litym |
US11315240B2 (en) * | 2016-05-18 | 2022-04-26 | Hoffmann-La Roche Inc. | System and method of tumor classification |
EP3532984B1 (en) * | 2016-10-27 | 2024-05-08 | Koninklijke Philips N.V. | Apparatus for determining cellular composition information in one or more tissue samples |
US11459568B2 (en) | 2016-10-31 | 2022-10-04 | University Of Massachusetts | Targeting microRNA-101-3p in cancer therapy |
CN106846310A (zh) * | 2017-01-19 | 2017-06-13 | 宁波江丰生物信息技术有限公司 | 一种基于免疫组化技术的病理辅助分析方法 |
WO2019020556A1 (en) * | 2017-07-24 | 2019-01-31 | Ventana Medical Systems, Inc. | METHODS AND SYSTEMS FOR ASSESSING INFILTRAT OF IMMUNE CELLS IN TUMOR SAMPLES |
US11814623B2 (en) | 2018-01-30 | 2023-11-14 | University Of Massachusetts | Methods of treating a wound using epigenetic regulation |
JP7411667B2 (ja) * | 2019-02-05 | 2024-01-11 | ヴェンタナ メディカル システムズ, インク. | ステージivの結腸直腸がんにおける免疫細胞浸潤の評価のための方法及びシステム |
WO2020245155A1 (en) | 2019-06-03 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for modulating a treatment regimen |
CN114556480A (zh) | 2019-11-07 | 2022-05-27 | 欧森纳治疗股份有限公司 | 肿瘤微环境的分类 |
CN111551546B (zh) * | 2020-06-01 | 2023-01-03 | 南京瑟斯检测科技有限公司 | 一种基于光学微腔结构超材料的免疫组化便捷检测方法 |
EP4172621A1 (en) | 2020-06-30 | 2023-05-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies |
CN115843335A (zh) | 2020-06-30 | 2023-03-24 | 国家医疗保健研究所 | 用于预测患有实体癌的患者在术前辅助治疗和根治性手术后复发和/或死亡风险的方法 |
CN113092202A (zh) * | 2021-03-25 | 2021-07-09 | 上海福君基因生物科技有限公司 | 一种胃癌预后预测装置 |
CN113515077A (zh) * | 2021-04-23 | 2021-10-19 | 重庆德方信息技术有限公司 | 人体细胞染色过程监控系统及方法 |
WO2023018085A1 (ko) * | 2021-08-10 | 2023-02-16 | 주식회사 루닛 | 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치 |
WO2023175366A1 (en) | 2022-03-17 | 2023-09-21 | Veracyte | Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer |
CN116646088B (zh) * | 2023-07-27 | 2023-12-01 | 广东省人民医院 | 一种预测方法、装置、设备及介质 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6215892B1 (en) * | 1995-11-30 | 2001-04-10 | Chromavision Medical Systems, Inc. | Method and apparatus for automated image analysis of biological specimens |
EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
AU2006333078B2 (en) * | 2005-12-19 | 2012-03-01 | Ventana Medical Systems, Inc. | Automated lean methods in anatomical pathology |
CN102165489B (zh) * | 2008-09-16 | 2015-11-25 | 赫斯托克斯公司 | 生物标志物表达的可再现量化 |
FR2964744B1 (fr) * | 2010-09-10 | 2015-04-03 | Univ Versailles St Quentin En Yvelines | Test pronostic de l'evolution d'une tumeur solide par analyse d'images |
-
2013
- 2013-06-14 AU AU2013276470A patent/AU2013276470B2/en active Active
- 2013-06-14 SG SG11201408107RA patent/SG11201408107RA/en unknown
- 2013-06-14 ES ES13731071T patent/ES2902879T3/es active Active
- 2013-06-14 CA CA2873278A patent/CA2873278C/en active Active
- 2013-06-14 JP JP2015516637A patent/JP6449765B2/ja active Active
- 2013-06-14 BR BR112014031143A patent/BR112014031143B8/pt active IP Right Grant
- 2013-06-14 WO PCT/EP2013/062405 patent/WO2013186374A1/en active Application Filing
- 2013-06-14 US US14/407,698 patent/US10317408B2/en active Active
- 2013-06-14 EP EP13731071.0A patent/EP2861986B1/en active Active
- 2013-06-14 DE DE13731071.0T patent/DE13731071T1/de active Pending
- 2013-06-14 KR KR1020157000987A patent/KR102179848B1/ko active IP Right Grant
- 2013-06-14 CN CN201380030888.7A patent/CN104541167B/zh active Active
-
2014
- 2014-11-17 IL IL235738A patent/IL235738B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20150023760A (ko) | 2015-03-05 |
EP2861986A1 (en) | 2015-04-22 |
CA2873278C (en) | 2021-10-26 |
ES2902879T3 (es) | 2022-03-30 |
JP2015525349A (ja) | 2015-09-03 |
WO2013186374A1 (en) | 2013-12-19 |
US10317408B2 (en) | 2019-06-11 |
IL235738A0 (en) | 2015-01-29 |
CN104541167A (zh) | 2015-04-22 |
BR112014031143A2 (pt) | 2017-08-08 |
EP2861986B1 (en) | 2021-11-10 |
AU2013276470B2 (en) | 2018-06-07 |
DE13731071T1 (de) | 2016-08-18 |
US20150153349A1 (en) | 2015-06-04 |
IL235738B (en) | 2019-02-28 |
CN104541167B (zh) | 2018-05-01 |
AU2013276470A1 (en) | 2014-11-27 |
CA2873278A1 (en) | 2013-12-19 |
BR112014031143B1 (pt) | 2022-03-03 |
KR102179848B1 (ko) | 2020-11-17 |
SG11201408107RA (en) | 2015-01-29 |
JP6449765B2 (ja) | 2019-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014031143B8 (pt) | Método para quantificar células imunes em tecidos tumorais e suas aplicações | |
BR112018009071A8 (pt) | método para preparar uma amostra, composição homogenizada, métodos para gerar dados, para tratar uma doença, de identificação de um marcador, para determinar o prognóstico de um câncer, para determinar um perfil fenotípico, para armazenar a composição homogenizada, para preparar uma amostra de tecido e preparar a composição homogenizada | |
BR112013009008A2 (pt) | métodos e kits para a detecção de células circulantes de tumor em pacientes pancreáticos com o uso de reagentes de detecção de captura e de coquetel poliespecíficos | |
BR112015020425A2 (pt) | sistema de imageamento por ultrassom inspecionar um objeto em um volume, método para fornecer uma imagem de ultrassom de um objeto em um volume, e, programa de computador | |
ES2531003T3 (es) | Procedimiento y dispositivo para detectar un artículo líquido | |
BRPI0714332B8 (pt) | aparelho de medição para enumeração de partículas em uma amostra, método para enumeração de partículas na amostra e meio legível de computador, para análise de uma amostra | |
WO2012110898A9 (en) | System and method for multi-scanner x-ray inspection | |
BR112014004376A2 (pt) | sistema para detecção automática da área ocupada da estrutura a partir de imagens oblíquas | |
BR112013003391B8 (pt) | Método para diagnosticar câncer pancreático em um indivíduo | |
BR112018006680A2 (pt) | supressor contendo nanomaterial conjugado por polímero solúvel em água e uso do mesmo | |
BR112015014821A2 (pt) | método e mídia legível por computador | |
BR112019011738A8 (pt) | Método implementado por computador para hemodinâmica de processamento de imagem e sistema para medir e/ou avaliar hemodinâmica em pelo menos uma parte do trato gastrointestinal, dispositivo médico eletrônico, e, programa de computador | |
IL235794B (en) | Super-resolution inspection system | |
BR112017021318A2 (pt) | método implementado por computador, e mídia legível por computador | |
ES2684758T3 (es) | Procedimiento para diagnosticar fibrosis hepática | |
MX363679B (es) | Metodo para diagnosticar cancer. | |
ES2563083T3 (es) | Procedimiento de preparación de una imagen de análisis virtual procesada | |
WO2012153964A3 (ko) | 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법 | |
IN2014DN10127A (pt) | ||
UA123587U (uk) | Спосіб кількісної оцінки відносної площі експресії маркерів при імуногістохімічному дослідженні тканин | |
Liu | Prenatal screening for Down's syndrome: Recent progress | |
Lu et al. | Characterization of ALK fusions in circulating tumor cells (CTCs) of NSCLC | |
Huang et al. | Correlation between fundic gland polyps and colorectal neoplasia: a case? control study | |
Zhang et al. | Application and development of point-of-care testing in domain of tumor markers | |
HU et al. | Meta Analysis of FCM DNA Ploidy in Distinguishing Benign Tumor from Malignant Ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/06/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) ; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) ; UNIVERSITE DE PARIS (FR) |
|
B25D | Requested change of name of applicant approved |
Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) ; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) ; UNIVERSITE PARIS CITE (FR) |